CROI 2017

February 13-16, 2017
Seattle, USA

The conference brought together top researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases.

DNDi took part in an oral presentation on the superboosting approach for children co-infected with HIV and tuberculosis.

 

Oral Presentation

Lopinavir/Ritonavir 1:1 superboosting overcomes rifampicin interactions in children
Rabie H*, Denti P, Lee J, Masango M, Coovadia A, Pillay S, Liberty A, McIIIeron H, Cotton M, Lallemant M

Abstract

View the presentation

* Presenting author

 

More information: